Adicet Bio, Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 23 trades on this page.
Chief Medical Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & CEO
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Scientific Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
10% owner
Common Stock
10% owner
Pre-Funded Warrant (Right to Buy)
Derivative security · not the ordinary share price.
10% owner
Common Stock
Excluded from the common-share buying signal. See trade details.
10% owner
Common Stock
Excluded from the common-share buying signal. See trade details.
10% owner
Common Stock
Excluded from the common-share buying signal. See trade details.
10% owner
Common Stock
10% owner
Common Stock
10% owner
Common Stock
10% owner
Common Stock
Chief Financial Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & CEO
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Technology Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Scientific Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Medical Officer | Stock Option (Right to Buy)Grant or award | Derivative units18,300Award · no purchase price | Non-cash award | Aug 5Filed Aug 7 · 2d later | SEC filing |
| President & CEO | Stock Option (Right to Buy)Grant or award | Derivative units55,000Award · no purchase price | Non-cash award | Jun 19Filed Jun 23 · 4d later | SEC filing |
| Chief Scientific Officer | Stock Option (Right to Buy)Grant or award | Derivative units55,000Award · no purchase price | Non-cash award | Jun 19Filed Jun 23 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units4,200Award · no purchase price | Non-cash award | Jun 21Filed Jun 23 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units4,200Award · no purchase price | Non-cash award | Jun 21Filed Jun 23 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units4,200Award · no purchase price | Non-cash award | Jun 21Filed Jun 23 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units4,200Award · no purchase price | Non-cash award | Jun 21Filed Jun 23 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units4,200Award · no purchase price | Non-cash award | Jun 21Filed Jun 23 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units4,200Award · no purchase price | Non-cash award | Jun 21Filed Jun 23 · 2d later | SEC filing |
| +310% owner | Common StockOther transaction | 250,000Price not reported | Unavailable | Apr 27Filed Apr 29 · 2d later | SEC filing |
| +310% owner | Pre-Funded Warrant (Right to Buy)Other transaction | Derivative units250,000Price not reported | Unavailable | Apr 27Filed Apr 29 · 2d later | SEC filing |
| +310% owner | Common StockPurchaseExcluded from purchase score | 74,577$7.04 / share | $525.02K | Feb 18Filed Apr 13 · 54d later | SEC filing |
| +310% owner | Common StockPurchaseExcluded from purchase score | 74,268$7.21 / share | $535.47K | Feb 19Filed Apr 13 · 53d later | SEC filing |
| +310% owner | Common StockPurchaseExcluded from purchase score | 74,751$7.27 / share | $543.44K | Feb 20Filed Apr 13 · 52d later | SEC filing |
| +710% owner | Common StockSale2 trades | 31,719avg $6.52 / share | $206.77K | Apr 7Filed Apr 9 · 2d later | 2 filings
|
| +710% owner | Common StockSale2 trades | 72,939avg $6.42 / share | $468.08K | Apr 8Filed Apr 9 · 1d later | 2 filings
|
| Chief Financial Officer | Stock Option (Right to Buy)Grant or award | Derivative units43,361Award · no purchase price | Non-cash award | Mar 25Filed Mar 27 · 2d later | SEC filing |
| President & CEO | Stock Option (Right to Buy)Grant or award | Derivative units468,555Award · no purchase price | Non-cash award | Mar 25Filed Mar 27 · 2d later | SEC filing |
| Chief Medical Officer | Stock Option (Right to Buy)Grant or award | Derivative units72,555Award · no purchase price | Non-cash award | Mar 25Filed Mar 27 · 2d later | SEC filing |
| Chief Technology Officer | Stock Option (Right to Buy)Grant or award | Derivative units43,361Award · no purchase price | Non-cash award | Mar 25Filed Mar 27 · 2d later | SEC filing |
| Chief Scientific Officer | Stock Option (Right to Buy)Grant or award | Derivative units72,555Award · no purchase price | Non-cash award | Mar 25Filed Mar 27 · 2d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
